Ischemia  >>  rivaroxaban  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rivaroxaban / Generic mfg.
ATLAS ACS TIMI 46, NCT00402597: Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The Trial)

Checkmark ATLAS ACS-TIMI 46 - Acute coronary syndrome
Jul 2013 - Jul 2013: ATLAS ACS-TIMI 46 - Acute coronary syndrome
Checkmark ATLAS ACS TIMI 46
Apr 2013 - Apr 2013: ATLAS ACS TIMI 46
Completed
2
3490
US
Rivaroxaban/Placebo, Placebo, Rivaroxaban
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Bayer
Acute Coronary Syndrome
10/08
10/08
TripleAXEL, NCT02042534: Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation

Completed
2
195
RoW
Rivaroxaban, Xarelto, Warfarin
Asan Medical Center, Bayer
Ischemic Stroke, Transient Ischemic Attack
12/15
12/15
GEMINI ACS 1, NCT02293395 / 2014-004266-26: A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome

Completed
2
3037
Japan, US, Canada, Europe, RoW
Acetylsalicylic acid, Aspirin, Rivaroxaban, JNJ-39039039, Bay 59-7939, Xarelto, Clopidogrel, Plavix, Ticagrelor, Brilinta
Janssen Research & Development, LLC, Bayer, Duke Clinical Research Institute, Harvard Medical School (HMS and HSDM)
Acute Coronary Syndrome
10/16
10/16

Download Options